IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Named Patient Import Basis – IPN

Access to Anti-Cancer Drugs for Lung Cancer Treatment in India. 

Lung cancer is a disease in which abnormal cells grow uncontrollably in the lungs. It is one of the most common types of cancer worldwide. Effective management may require targeted therapies, immunotherapies, or specialized medications that are sometimes not available in India.

We Help Patients Access Anti-Cancer Drugs

India Pharma Network (IPN) is a leading healthcare facilitation organization in India, specializing in access to imported and specialized medicines for lung cancer patients. With 10+ years of experience, IPN helps patients, doctors, and hospitals import essential therapies not readily available in India, strictly on a Named Patient Import Basis and for personal use only.

Headquartered in New Delhi, with branch offices in Delhi, Mumbai, Kolkata, Hyderabad, Bangaluru, Pune, Lucknow, and Chandigarh, IPN ensures a regulatory-compliant and patient-focused process for accessing lung cancer treatments.

Learn About the Import Process

Request Information

If you wish to understand whether a specific FDA-approved medicine may be eligible for lawful import assistance, you may submit an inquiry for informational review only.

Contact Us to learn about the process and documentation requirements.

What We Do

We assist with the lawful sourcing and import coordination of prescription medicines that:

  • Are approved by the United States Food and Drug Administration (US FDA)
  • Are not marketed or available in India
  • Are prescribed by a licensed medical professional
  • Are imported strictly under permitted personal-use or named-patient provisions

Learn about the eligibility, process, and documentation requirements to understand how lawful access may be facilitated.

Related products

Contact us to learn about the process.

We help patients and caregivers understand and coordinate the lawful import process for certain US FDA-approved lung cancer medicines that are not currently available in India. We support documentation and process coordination only.

Visit Us

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Contact Us

M: 9811747774 or 9891296838
P: +91-11-26532129 / 26536398

Email Us

info@indianpharmanetwork.co.in 
urgent@indianpharmanetwork.co.in 

Learn How it Works!

Frequently Asked Questions

What does Named Patient Import Basis mean?

A Named Patient Import Basis import means the medicine is supplied exclusively for an individual patient, based on a doctor’s prescription. It cannot be sold or distributed commercially.

Which lung cancer medicines can be imported through IPN?

Lung cancer medicines include a range of targeted therapies, immunotherapies, chemotherapy agents, and specialty drugs used to manage and treat lung cancer. These medicines may sometimes be unavailable in India, requiring import on a Named Patient Basis.

Specialty high-value medications not approved or marketed in India

Why Choose India Pharma Network for Lung Cancer Medicines?
  • 10+ years of expertise in import medicine facilitation.
  • Specialized knowledge in oncology and lung cancer therapies.
  • Pan-India presence.
  • Compliance-focused Named Patient Import Basis facilitation.
  • Transparent, patient-centric support.
How can I access lung cancer medicines not available in India?

Access requires:

  1. Valid prescription from a Registered Medical Practitioner (RMP)
  2. Submission of Form 12A to Indian authorities
  3. Supporting medical documentation as required

India Pharma Network (IPN) provides end-to-end facilitation, including regulatory coordination and import logistics.

Who Can Access Lung Cancer Medicines Through IPN?
  • Patients seeking advanced lung cancer therapies unavailable locally.
  • Oncologists and treating physicians prescribing personalized treatments.
  • Hospitals and cancer care centers coordinating therapy for patients.

All medicines are facilitated only on a Named Patient Basis and with a valid prescription from a Registered Medical Practitioner (RMP).

How long does it take to import lung cancer medicines to India?

The timeline depends on:

  • Regulatory approval from authorities
  • Supplier availability
  • Shipping and logistics

IPN provides regular updates to patients, doctors, and hospitals throughout the process.

How much do imported lung cancer medicines cost in India?

Medicines can be legally imported under Indian regulatory provisions (e.g., Form 12A) on a Named Patient Basis and for personal use only. IPN ensures compliance with all applicable regulations.

Costs vary based on medicine type, dosage, quantity, shipping, and regulatory fees. IPN can provide an estimated pharmaceutical cost in India after reviewing the prescription and requirements.

How can I contact IPN for lung cancer medicine access?

Contact India Pharma Network – Lung Cancer Therapy Support

For inquiries regarding lung cancer medicine availability, import process, or pharmaceutical product cost in India, contact:

India Pharma Network (IPN)

Head Office: New Delhi
Branch Offices: Delhi | Kolkata | Mumbai | Pune | Hyderabad | Bengaluru | Lucknow

Mr. Tarun: +91 9891 296 838
Mr. Neeraj: +91 9811 747 774
Email: query@indianpharmanetwork.co.in

Important Notice:
This FAQ is for informational purposes only and does not provide medical advice. All medicines require a valid prescription from a licensed healthcare professional. Importation is subject to Indian laws and approval by relevant authorities.

Indian Pharma Network has served following cities in India – Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.